Abstract:Background: To evaluate the performance of fully automated deep learning (DL) algorithm for staging hepatic fibrosis and distinguishing fibrosis from normal people based on MR images with or without non-image information.Methods: 500 patients were retrospectively enrolled from two hospitals. Model DL were built using delayed phase MR images to assess fibrosis stages. In addition, different models which combined model DL with non-image information including biomarkers (APRI and FIB-4), virus status (hepatitis B and C virus tests), and MR information (manufactures and static magnetic field) were built. The AUROCs were compared between different models using Delong test, the sensitivity and specificity of both model DL and model Full (model DL combined with all non-image information) were compared with experienced radiologists and biomarkers using McNemar’s test.Findings: In the test set, the AUROC (with 95% confidence intervals) values of model Full for diagnosing fibrosis stages F0-4, F1-4, F2-4, F3-4 and F4 were 0.99 (0.94-1.00), 0.98 (0.93-0.99), 0.90 (0.83-0.95), 0.81 (0.73-0.88) and 0.84 (0.76-0.90), respectively, which outperformed model DL on diagnosing F0-4 and F1-4. Compared with the radiologists, model Full showed better specificity for fibrosis stage F0-4, better sensitivity for the other four classification tasks. While compared with biomarkers, both model DL and model Full showed significantly higher specificity in staging F3-4 and F4.Interpretation: Deep learning-based model DL and model Full using delayed phase MR images provides a promising non-invasive assessment tool for the staging liver fibrosis with a performance superior to experienced radiologists and biomarkers (APRI and FIB-4) , which may be helpful to screen out CLD patients from normal individuals, instruct which patients need treatment and prevent patients from progressing to decompensated cirrhosis by paying more attention to patients with compensated cirrhosis (F4).Funding: This work was supported by the National Natural Science Foundation of China (grant numbers 81401406) and Innovative Research Team of High-level Local Universities in Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscriptDeclaration of Interest: The authors declare that they have no conflict of interestEthical Approval: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

A Deep Learning Model with Data Integration of Ultrasound Contrast-Enhanced Micro-Flow Cines, B-mode Images, and Clinical Parameters for Diagnosing Significant Liver Fibrosis in Patients with Chronic Hepatitis B

Diagnosis of significant liver fibrosis in patients with chronic hepatitis B using a deep learning-based data integration network

Deep Learning Radiomics for Focal Liver Lesions Diagnosis on Long-Range Contrast-Enhanced Ultrasound and Clinical Factors

The Value of Ultrasonic Elastographic Parameters in the Evaluation of Chronic Hepatitis B Liver Fibrosis

Automatic Diagnosis of Significant Liver Fibrosis From Ultrasound B-Mode Images Using a Handcrafted-Feature-Assisted Deep Convolutional Neural Network

Machine Learning-Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients With Hepatic Steatosis

Development and Validation of a Non-Invasive Model for Predicting Liver Cirrhosis in Patients with Chronic Hepatitis B

Ultrasound Liver Fibrosis Diagnosis using Multi-indicator guided Deep Neural Networks

[Computer-Aided Assessment of Liver Fibrosis Progression in Patients with Chronic Hepatitis B: an Exploratory Research].

Deep Learning-Based Automated Assessment of Hepatic Fibrosis on Magnetic Resonance Images and Non-Image Data

Development and validation of a novel score for fibrosis staging in patients with chronic hepatitis B.

Deep Learning for Accurate Diagnosis of Liver Tumor Based on Magnetic Resonance Imaging and Clinical Data

Development of a Machine Learning-Based Model to Predict Hepatic Inflammation in Chronic Hepatitis B Patients with Concurrent Hepatic Steatosis: a Cohort Study

Noninvasive Assessment of Liver Fibrosis and Inflammation in Chronic Hepatitis B: A Dual-task Convolutional Neural Network (dtcnn) Model Based on Ultrasound Shear Wave Elastography.

Deep Learning for Approaching Hepatocellular Carcinoma Ultrasound Screening Dilemma: Identification of -Fetoprotein-Negative Hepatocellular Carcinoma From Focal Liver Lesion Found in High-Risk Patients

Comparing radiomics models with different inputs for accurate diagnosis of significant fibrosis in chronic liver disease

Clinical Prediction of HBV and HCV Related Hepatic Fibrosis Using Machine Learning

Machine Learning Assessment for Severity of Liver Fibrosis for Chronic HBV Based on Physical Layer with Serum Markers.

Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study.

A machine learning-based model analysis for serum markers of liver fibrosis in chronic hepatitis B patients

Deep Learning for Approaching Hepatocellular Carcinoma Ultrasound Screening Dilemma: Identification of α-Fetoprotein-Negative Hepatocellular Carcinoma From Focal Liver Lesion Found in High-Risk Patients